IL224452A - Compounds [2,4,1] Thadiazine –1,1– Dioxide Prepared and Used in Drug Preparation - Google Patents

Compounds [2,4,1] Thadiazine –1,1– Dioxide Prepared and Used in Drug Preparation

Info

Publication number
IL224452A
IL224452A IL224452A IL22445213A IL224452A IL 224452 A IL224452 A IL 224452A IL 224452 A IL224452 A IL 224452A IL 22445213 A IL22445213 A IL 22445213A IL 224452 A IL224452 A IL 224452A
Authority
IL
Israel
Prior art keywords
thiadiazine
medicaments
fused
preparation
dioxide compounds
Prior art date
Application number
IL224452A
Other languages
English (en)
Hebrew (he)
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of IL224452A publication Critical patent/IL224452A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL224452A 2010-08-10 2013-01-28 Compounds [2,4,1] Thadiazine –1,1– Dioxide Prepared and Used in Drug Preparation IL224452A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10
PCT/JP2011/068497 WO2012020848A1 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof

Publications (1)

Publication Number Publication Date
IL224452A true IL224452A (en) 2017-11-30

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
IL224452A IL224452A (en) 2010-08-10 2013-01-28 Compounds [2,4,1] Thadiazine –1,1– Dioxide Prepared and Used in Drug Preparation

Country Status (39)

Country Link
US (11) US9150591B2 (cg-RX-API-DMAC7.html)
EP (1) EP2603513B1 (cg-RX-API-DMAC7.html)
JP (2) JP5788496B2 (cg-RX-API-DMAC7.html)
KR (1) KR101852215B1 (cg-RX-API-DMAC7.html)
CN (2) CN103180326B (cg-RX-API-DMAC7.html)
AR (1) AR082618A1 (cg-RX-API-DMAC7.html)
AU (1) AU2011290126B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013002250B1 (cg-RX-API-DMAC7.html)
CA (1) CA2807460C (cg-RX-API-DMAC7.html)
CL (1) CL2013000380A1 (cg-RX-API-DMAC7.html)
CO (1) CO6680700A2 (cg-RX-API-DMAC7.html)
CR (1) CR20130066A (cg-RX-API-DMAC7.html)
CY (1) CY1123507T1 (cg-RX-API-DMAC7.html)
DK (1) DK2603513T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2013000030A (cg-RX-API-DMAC7.html)
EA (1) EA022078B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP13012478A (cg-RX-API-DMAC7.html)
ES (1) ES2793723T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20156216B (cg-RX-API-DMAC7.html)
HR (1) HRP20200844T1 (cg-RX-API-DMAC7.html)
HU (1) HUE049460T2 (cg-RX-API-DMAC7.html)
IL (1) IL224452A (cg-RX-API-DMAC7.html)
LT (1) LT2603513T (cg-RX-API-DMAC7.html)
MA (1) MA34509B1 (cg-RX-API-DMAC7.html)
MX (1) MX349470B (cg-RX-API-DMAC7.html)
MY (1) MY165908A (cg-RX-API-DMAC7.html)
NZ (1) NZ607593A (cg-RX-API-DMAC7.html)
PE (1) PE20131116A1 (cg-RX-API-DMAC7.html)
PH (1) PH12013500247A1 (cg-RX-API-DMAC7.html)
PL (1) PL2603513T3 (cg-RX-API-DMAC7.html)
PT (1) PT2603513T (cg-RX-API-DMAC7.html)
RS (1) RS60311B1 (cg-RX-API-DMAC7.html)
SG (1) SG187656A1 (cg-RX-API-DMAC7.html)
SI (1) SI2603513T1 (cg-RX-API-DMAC7.html)
TW (1) TWI504604B (cg-RX-API-DMAC7.html)
UA (1) UA111594C2 (cg-RX-API-DMAC7.html)
UY (1) UY33551A (cg-RX-API-DMAC7.html)
WO (1) WO2012020848A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201301120B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20200844T1 (hr) * 2010-08-10 2020-08-21 Takeda Pharmaceutical Company Limited Heterociklički spoj i njegova uporaba kao pozitivnog alosteričnog modulatora ampa-receptora
WO2012137982A2 (en) 2011-04-05 2012-10-11 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
WO2013118845A1 (ja) * 2012-02-08 2013-08-15 武田薬品工業株式会社 複素環化合物およびその用途
US20150011554A1 (en) * 2013-06-13 2015-01-08 Veroscience Llc Compositions and Methods for Treating Metabolic Disorders
EA028637B1 (ru) 2013-06-27 2017-12-29 Пфайзер Инк. Гетероароматические соединения и их применение в качестве лигандов к дофаминовым d1-рецепторам
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
HUE049827T2 (hu) 2013-12-03 2020-10-28 Fmc Corp Pirrolidinonok mint herbicidek
KR102479858B1 (ko) 2014-07-02 2022-12-21 에프엠씨 코포레이션 피페리디논계 제초제
CN107001260B (zh) 2014-12-08 2020-11-10 Fmc公司 3-氧基-3-(芳氨基)丙酸酯、其制备方法、以及其在制备吡咯烷酮中的用途
US10405547B2 (en) 2015-04-10 2019-09-10 Fmc Corporation Substituted cyclic amides as herbicides
US10582709B2 (en) 2015-04-27 2020-03-10 Fmc Corporation Butyrolactones as herbicides
WO2016176457A1 (en) * 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
UA120304C2 (uk) * 2015-04-29 2019-11-11 Янссен Фармацевтика Нв Азабензімідазоли та їх використання як модуляторів рецепторів ampa
WO2016182780A1 (en) 2015-05-12 2016-11-17 E I Du Pont De Nemours And Company Aryl substituted bicyclic compounds as herbicides
EP3303287B1 (en) 2015-05-29 2020-12-16 FMC Corporation Substituted cyclic amides as herbicides
CN107709310B (zh) 2015-06-02 2021-09-24 Fmc公司 取代的环酰胺及其作为除草剂的用途
BR112018001964B1 (pt) 2015-07-31 2022-05-10 Fmc Corporation Composto, composição herbicida, mistura herbicida e método para o controle docrescimento de vegetação indesejada
EP3331892B1 (en) * 2015-08-06 2019-07-03 F.Hoffmann-La Roche Ag Processes for the preparation of galnac acid derivatives
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
CN110312712B (zh) 2016-12-21 2023-06-23 Fmc公司 硝酮除草剂
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
JP7201609B2 (ja) 2017-03-21 2023-01-10 エフ エム シー コーポレーション ピロリジノン及びこれらを調製するためのプロセス
MX2019011090A (es) 2017-03-21 2019-11-18 Fmc Corp Mezcla herbicida, composición y método.
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
EP3693360B1 (en) * 2017-10-06 2023-12-13 Takeda Pharmaceutical Company Limited Heterocyclic compounds
EP3693368B1 (en) * 2017-10-06 2023-12-06 Takeda Pharmaceutical Company Limited Heterocyclic compound
PL4031552T3 (pl) 2019-09-16 2025-03-17 Takeda Pharmaceutical Company Limited Pochodne azolowo-skondensowanych pirydazyn-3(2h)-onów
JP2023526249A (ja) * 2020-05-15 2023-06-21 武田薬品工業株式会社 うつ病の処置
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025224508A1 (en) 2024-04-22 2025-10-30 Takeda Pharmaceutical Company Limited Pharmaceutical composition for treating depressive disorders

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (cg-RX-API-DMAC7.html) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) * 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) * 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
WO2001032013A1 (en) 1999-11-04 2001-05-10 Colorado State University Research Foundation Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MXPA04003297A (es) * 2001-10-10 2004-07-23 Neurosearch As Derivados novedosos de benzotiacina su preparacion y uso.
FR2833955B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) * 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2655376A1 (en) 2006-06-23 2007-12-27 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
EP2102153A1 (en) * 2006-12-11 2009-09-23 Eli Lilly & Company Ampa receptor potentiators
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
WO2009061699A1 (en) 2007-11-05 2009-05-14 Schering Corporation Gamma secretase modulators
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
US20110118236A1 (en) 2008-03-25 2011-05-19 Michiyo Mochizuki Heterocyclic compound
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
EP2356115A1 (en) 2008-11-06 2011-08-17 Schering Corporation Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
JPWO2011007756A1 (ja) 2009-07-13 2012-12-27 武田薬品工業株式会社 複素環化合物及びその用途
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
HRP20200844T1 (hr) * 2010-08-10 2020-08-21 Takeda Pharmaceutical Company Limited Heterociklički spoj i njegova uporaba kao pozitivnog alosteričnog modulatora ampa-receptora

Also Published As

Publication number Publication date
US20150353578A1 (en) 2015-12-10
NZ607593A (en) 2015-01-30
US20170022222A1 (en) 2017-01-26
MY165908A (en) 2018-05-18
WO2012020848A1 (en) 2012-02-16
BR112013002250A2 (pt) 2016-05-24
GEP20156216B (en) 2015-01-12
TW201217386A (en) 2012-05-01
EP2603513B1 (en) 2020-03-11
MA34509B1 (fr) 2013-09-02
AU2011290126A1 (en) 2013-03-07
MX2013001614A (es) 2013-07-05
HUE049460T2 (hu) 2020-09-28
US20190263832A1 (en) 2019-08-29
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
CN103180326A (zh) 2013-06-26
KR101852215B1 (ko) 2018-04-25
DK2603513T3 (da) 2020-06-15
US8575154B2 (en) 2013-11-05
US20130184266A1 (en) 2013-07-18
PT2603513T (pt) 2020-06-08
US20240360156A1 (en) 2024-10-31
CN104926837A (zh) 2015-09-23
US20130190291A1 (en) 2013-07-25
CR20130066A (es) 2013-05-03
CA2807460C (en) 2018-09-18
US8778934B2 (en) 2014-07-15
ES2793723T3 (es) 2020-11-16
HRP20200844T1 (hr) 2020-08-21
US11279713B2 (en) 2022-03-22
US20150073137A1 (en) 2015-03-12
PE20131116A1 (es) 2013-10-24
SG187656A1 (en) 2013-03-28
TWI504604B (zh) 2015-10-21
US9499568B2 (en) 2016-11-22
PL2603513T3 (pl) 2020-07-27
CL2013000380A1 (es) 2013-05-31
PH12013500247A1 (en) 2013-03-11
ECSP13012478A (es) 2013-04-30
US9884875B2 (en) 2018-02-06
RS60311B1 (sr) 2020-07-31
KR20130138738A (ko) 2013-12-19
JP5788496B2 (ja) 2015-09-30
CY1123507T1 (el) 2022-03-24
US20180162875A1 (en) 2018-06-14
CO6680700A2 (es) 2013-05-31
US20200317692A1 (en) 2020-10-08
DOP2013000030A (es) 2013-03-15
EA201390222A1 (ru) 2013-08-30
EA022078B1 (ru) 2015-10-30
JP2016006080A (ja) 2016-01-14
US20120077799A1 (en) 2012-03-29
LT2603513T (lt) 2020-05-25
AR082618A1 (es) 2012-12-19
JP6113789B2 (ja) 2017-04-12
BR112013002250B1 (pt) 2020-10-27
ZA201301120B (en) 2014-04-30
MX349470B (es) 2017-07-31
CA2807460A1 (en) 2012-02-16
AU2011290126B2 (en) 2016-01-07
WO2012020848A8 (en) 2012-09-27
UY33551A (es) 2012-03-30
US20140080817A1 (en) 2014-03-20
EP2603513A1 (en) 2013-06-19
JP2013535408A (ja) 2013-09-12
US8916551B2 (en) 2014-12-23
US10654874B2 (en) 2020-05-19
CN103180326B (zh) 2015-06-10
US9150591B2 (en) 2015-10-06

Similar Documents

Publication Publication Date Title
IL224452A (en) Compounds [2,4,1] Thadiazine –1,1– Dioxide Prepared and Used in Drug Preparation
IL221160A (en) 4,2,1-triazine-3-amine derivatives, a process for their preparation and use for drug preparation
IL268756B (en) Piperazine-2,5-dione derivatives, pharmaceutical preparations containing them and their use for the preparation of medicines
IL213622A (en) Benzamide compounds are being used and their use in making a drug
IL213019A (en) Derivatives 1-Azo-3-Terroyl-Azoline, Pharmaceutical Preparations Containing and Using Them
IL233282A (en) Crystalline Forms of 5- (2,6-Di-4-Morpholinyl-4-Pyrimidinyl) -4-Trifluoromethylpyridine-2-Amine Monohydrochloride
IL222268A (en) Preserved pyrollo-pyridines, containing pharmaceutical preparations, combined preparations containing them and their use in the preparation of medicines
IL206952A (en) History of Aminodia Hydrothiazine, medicinal preparations containing them, and their use in the preparation of medicines
IL211391B (en) Benzo[d] oxazole-2-carboxamido-4-phenyl-thiophene-carboxylate derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL212573A (en) Aryl Methyl Benzokinazulinone Compounds
IL217490A (en) History of pyridine-4-il, pharmaceutical preparations containing them and their use in the preparation of medicines
PT3042910T (pt) 2'-espiro-nucleósidos para utilização na terapia da hepatite c
IL219876A (en) Antibodies against human 1h-7b or its fragment, preparations containing them and their use in the preparation of drugs
IL232382A (en) History of Foro [3, 2 – d] Pyrimidine, preparations containing them and their use in the preparation of drugs
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
IL218490A (en) Oxazolopyrimidinones dihydro hydroxybencyalkyloxymethyl are converted, preparations containing them and their use in the preparation of pharmaceutical preparations
IL232325A0 (en) 18-methyl-7,6-methylene-3-oxo-17-paragan-4-en-21, 17b-carbolactones, pharmaceutical preparations containing these compounds and their use for the treatment of endometrial disease
IL234166B (en) Isoindoline compounds, a pharmaceutical composition containing it and its use in the preparation of a medicine
IL213517A (en) Sulfonamide derivatives, pharmaceuticals containing them and their use in the preparation of drugs
IL223795A (en) History of Tetrahydro-Pyrido-Pyrimidine
ZA201209632B (en) Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof
PL2739615T3 (pl) Fenylo-3-aza-bicyklo[3.1.0]heks-3-ylo-metanony i ich zastosowanie jako leki
IL219120A (en) Cyclohaphtha pyridinyl derivatives and their use in drug preparation
SI2655375T1 (sl) Derivati pirimidinona, njihova priprava in njihova farmacevtska uporaba
IL207972A (en) History of pyridine-2-ram, pharmaceuticals containing them and their use in the preparation of medicines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed